ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd (TAK)

13.39
-0.31
(-2.26%)
Closed February 01 3:00PM
13.39
0.00
(0.00%)
After Hours: 6:17PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
13.39
Bid
-
Ask
-
Volume
2,283,765
13.37 Day's Range 13.57
12.575 52 Week Range 15.08
Market Cap
Previous Close
13.70
Open
13.57
Last Trade
156949
@
13.39
Last Trade Time
Financial Volume
US$ 30,655,121
VWAP
13.4231
Average Volume (3m)
1,851,449
Shares Outstanding
3,138,026,928
Dividend Yield
4.62%
PE Ratio
0.57
Earnings Per Share (EPS)
45.91
Revenue
4.28T
Net Profit
144.07B

About Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Headquarters
Chuo, Tokyo, Jpn
Founded
1984
Takeda Pharmaceutical Company Ltd is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker TAK. The last closing price for Takeda Pharmaceutical was US$13.70. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of US$ 12.575 to US$ 15.08.

Takeda Pharmaceutical currently has 3,138,026,928 shares outstanding. The market capitalization of Takeda Pharmaceutical is US$42.99 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 0.57.

TAK Latest News

武田薬品工業: ジュリー・キムが2026年6月にクリストフ・ウェバーの後任として就任

当社代表取締役社長CEOのクリストフ・ウェバーが12年間の勤務を経て、2026年6月に当社から退任 数年にわたる後継者計画プロセスを経て、U.S. ビジネスユニットプレジデントのジュリー・キムをウェバー氏の後任...

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Revenue Growth of +9.8% at Actual Exchange Rates (AER); +4.5% at Constant Exchange Rate (CER) Driven by Strong Momentum of Growth & Launch Products (+14.6% at CER) Core Operating Profit...

Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age

Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age Canada NewsWire TORONTO, Jan. 29, 2025 TORONTO, Jan...

Takeda a été nommée au palmarès des meilleurs employeurs au Canada pour une troisième année consécutive

Takeda a été nommée au palmarès des meilleurs employeurs au Canada pour une troisième année consécutive Canada NewsWire TORONTO, le 21 janv. 2025 Cette...

Santé Canada accorde à Takeda une autorisation de mise en marché de FRUZAQLA (MC) (fruquintinib) pour le traitement du cancer colorectal métastatique (CCRm)

Santé Canada accorde à Takeda une autorisation de mise en marché de FRUZAQLA (MC) (fruquintinib) pour le traitement du cancer colorectal métastatique (CCRm) Canada...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.473.6377708978312.9213.8812.92228311713.41266156DR
40.141.0566037735813.2513.8812.86218660113.20701639DR
12-0.39-2.8301886792513.7814.0312.86185144913.36162393DR
26-0.18-1.3264554163613.5715.0812.86185497613.91067113DR
52-1.31-8.9115646258514.715.0812.575182844413.80416398DR
156-1.01-7.0138888888914.417.1512.28220147714.50048593DR
260-6.05-31.12139917719.4420.484412.28216668415.36344477DR

TAK - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical share price?
The current share price of Takeda Pharmaceutical is US$ 13.39
How many Takeda Pharmaceutical shares are in issue?
Takeda Pharmaceutical has 3,138,026,928 shares in issue
What is the market cap of Takeda Pharmaceutical?
The market capitalisation of Takeda Pharmaceutical is USD 42.99B
What is the 1 year trading range for Takeda Pharmaceutical share price?
Takeda Pharmaceutical has traded in the range of US$ 12.575 to US$ 15.08 during the past year
What is the PE ratio of Takeda Pharmaceutical?
The price to earnings ratio of Takeda Pharmaceutical is 0.57
What is the cash to sales ratio of Takeda Pharmaceutical?
The cash to sales ratio of Takeda Pharmaceutical is 0.02
What is the reporting currency for Takeda Pharmaceutical?
Takeda Pharmaceutical reports financial results in JPY
What is the latest annual turnover for Takeda Pharmaceutical?
The latest annual turnover of Takeda Pharmaceutical is JPY 4.28T
What is the latest annual profit for Takeda Pharmaceutical?
The latest annual profit of Takeda Pharmaceutical is JPY 144.07B
What is the registered address of Takeda Pharmaceutical?
The registered address for Takeda Pharmaceutical is 4-1-1 DOSHOMACHI, CHUO-KU, CHUO, TOKYO, 540-8645
What is the Takeda Pharmaceutical website address?
The website address for Takeda Pharmaceutical is www.takeda.co.jp
Which industry sector does Takeda Pharmaceutical operate in?
Takeda Pharmaceutical operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MBIMBIA Inc
US$ 7.11
(15.42%)
2.37M
ALURAllurion Technologies Inc
US$ 6.07
(13.46%)
581.31k
SESSES AI Corporation
US$ 1.19
(13.33%)
25.04M
ENFYEnlightify Inc
US$ 1.36
(12.40%)
95.7k
LITBLightInTheBox Holding Co Ltd
US$ 1.155
(12.14%)
17.6k
DECKDeckers Outdoor
US$ 177.46
(-20.46%)
15.07M
BZHBeazer Homes USA Inc New
US$ 22.18
(-19.93%)
2.15M
VSTSVestis Corporation
US$ 14.00
(-11.62%)
6.18M
KOREKORE Group Holdings Inc
US$ 2.29
(-9.13%)
37.08k
NOVASunnova Energy International Inc
US$ 2.565
(-9.04%)
14.69M
FFord Motor Company
US$ 10.08
(-0.79%)
103.99M
QBTSD Wave Quantum Inc
US$ 5.94
(5.32%)
75.07M
BBDBanco Bradesco SA
US$ 2.12
(0.47%)
55.89M
NUNu Holdings Ltd
US$ 13.25
(-1.41%)
48.21M
VZVerizon Communications Inc
US$ 39.39
(-0.20%)
45.19M

TAK Discussion

View Posts
Monksdream Monksdream 10 months ago
TAK over $10
👍️0
Boing x 2 Boing x 2 2 years ago
Just saying,

https://www.takeda.com/newsroom/newsreleases/2022/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-us-food-and-drug-administration

4 months or less until an answer. Expedited review is six months or less now. It was accepted Nov 22nd.

Big if we get FDA apprvoval. ETF's in the know are sucking up shares.

Other approved drug has serious side effects vs. ours.

300M cases a year from mosquito bites.

Boing X 2
👍️0
Phosphene Phosphene 4 years ago
Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

https://www.businesswire.com/news/home/20201208005955/en/Takeda%E2%80%99s-Pipeline-Has-Potential-to-Contribute-Significantly-to-Revenue-Growth-Over-Next-Decade
👍️0
Phosphene Phosphene 4 years ago
Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO

https://www.reuters.com/article/health-coronavirus-takeda-vaccines-idUSKBN27M0F7
👍️0
Phosphene Phosphene 4 years ago
MIT-Takeda program launches

Research projects will harness the power of artificial intelligence to positively impact human health.

https://news.mit.edu/2020/mit-takeda-program-launches-research-ai-and-human-health-0618
👍️0
rising rising 7 years ago
Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

ADR is 3:1 - NICE!
60 percent upside
Added 36.83 US stock
Added 29.38 US cash


Not a bad deal!
👍️0
rising rising 7 years ago
So how does the Shire shareholder make out on this deal?

Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

Where is the 60percent premium to Close of March 27 2018 at shire 128.87
👍️0
trendmkr trendmkr 9 years ago
Takeda article: enGene Shines with a Host of Big Name Collaborations

http://marketexclusive.com/engene-shines-with-a-host-of-big-name-collaborations/1281/
👍️0

Your Recent History

Delayed Upgrade Clock